MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1182/blood-2009-10-247965

Медицинская библиотека · Blood · 2010

Improved outcome with pulses of vincristine and corticosteroids in continuation therapy of children with average risk acute lymphoblastic leukemia (ALL) and lymphoblastic non-Hodgkin lymphoma (NHL): report of the EORTC randomized phase 3 trial 58951.

De Moerloose Barbara, Suciu Stefan, Bertrand Yves, Mazingue Françoise, Robert Alain, Uyttebroeck Anne, Yakouben Karima, Ferster Alice, Margueritte Geneviève, Lutz Patrick, Munzer Martine, Sirvent Nicolas, Norton Lucilia, Boutard Patrick, Plantaz Dominique, Millot Frederic, Philippet Pierre, Baila Liliana, Benoit Yves, Otten Jacques, Children's Leukemia Group of the European Organisation for Research and Treatment of Cancer (EORTC)

Клиническое исследование III фазыСтатьяМногоцентровое исследованиеРандомизированное исследованиеПоддержка NIH: внешняя программаПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

The European Organisation for Research and Treatment of Cancer 58951 trial for children with acute lymphoblastic leukemia (ALL) or non-Hodgkin lymphoma (NHL) addressed 3 randomized questions, including the evaluation of dexamethasone (DEX) versus prednisolone (PRED) in induction and, for average-risk patients, the evaluation of vincristine and corticosteroid pulses during continuation therapy. The corticosteroid used in the pulses was that assigned at induction. Overall, 411 patients were randomly assigned: 202 initially randomly assigned to PRED (60 mg/m(2)/d), 201 to DEX (6 mg/m(2)/d), and 8 nonrandomly assigned to PRED. At a median follow-up of 6.3 years, there were 19 versus 34 events for pulses versus no pulses; 6-year disease-free survival (DFS) rate was 90.6% (standard error [SE], 2.1%) and 82.8% (SE, 2.8%), respectively (hazard ratio [HR] = 0.54; 95% confidence interval, 0.31-0.94; P = .027). The effect of pulses was similar in the PRED (HR = 0.56) and DEX groups (HR = 0.59) but more pronounced in girls (HR = 0.24) than in boys (HR = 0.71). Grade 3 to 4 hepatic toxicity was 30% versus 40% in pulses versus no pulses group and grade 2 to 3 osteonecrosis was 4.4% versus 2%. For average-risk patients treated according to Berlin-Frankfurt-Muenster-based protocols, pulses should become a standard component of therapy.

Для цитирования: De Moerloose Barbara, Suciu Stefan, Bertrand Yves, Mazingue Françoise, Robert Alain, Uyttebroeck Anne, Yakouben Karima, Ferster Alice, Margueritte Geneviève, Lutz Patrick, Munzer Martine, Sirvent Nicolas, Norton Lucilia, Boutard Patrick, Plantaz Dominique, Millot Frederic, Philippet Pierre, Baila Liliana, Benoit Yves, Otten Jacques, Children's Leukemia Group of the European Organisation for Research and Treatment of Cancer (EORTC). Improved outcome with pulses of vincristine and corticosteroids in continuation therapy of children with average risk acute lymphoblastic leukemia (ALL) and lymphoblastic non-Hodgkin lymphoma (NHL): report of the EORTC randomized phase 3 trial 58951.. Blood. 2010. DOI: 10.1182/blood-2009-10-247965.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.